5
Noble Explochem Ltd
506991 BSE
Noble Explochem Ltd
Commodities BSE: 506991 Chemicals & Petrochemicals
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Noble Explochem Ltd insights
29 extracted metrics + investor summaries across FY07–FY19.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
2- Company has low interest coverage ratio.
- Contingent liabilities of Rs.26.3 Cr.
Growth Rate
Revenue Growth
-
Net Income Growth
-97.00% →
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Results
| Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.22 | 0.38 | 0.08 | 0.13 | 0.12 | 0.26 | 0.18 | 0.17 | 0.25 | 0.6 | 0.23 | 0.24 | 0.4 |
| Operating Profit | -0.22 | -0.38 | -0.08 | -0.13 | -0.12 | -0.26 | -0.18 | -0.17 | -0.25 | -0.6 | -0.23 | -0.24 | -0.4 |
| Other Income | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | 0.07 | 0 | 0.01 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.22 | -0.34 | -0.08 | -0.13 | -0.12 | -0.26 | -0.18 | -0.17 | -0.1 | -0.53 | -0.23 | -0.24 | -0.4 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.22 | -0.34 | -0.08 | -0.13 | -0.12 | -0.26 | -0.18 | -0.17 | -0.1 | -0.53 | -0.23 | -0.24 | -0.4 |
| EPS in Rs | -0.11 | -0.18 | -0.04 | -0.07 | -0.06 | -0.14 | -0.09 | -0.09 | -0.05 | -0.28 | -0.12 | -0.12 | -0.21 |
Profit & Loss
| Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 35.04 | 10.07 | 0.51 | 13.62 | 0.99 | 0.89 | 0.84 | 0.82 | 0.84 | 0.91 | 0.59 | 1.2 | 1.47 |
| Operating Profit | -23.11 | -10.07 | -0.51 | -13.62 | -0.99 | -0.89 | -0.84 | -0.82 | -0.84 | -0.91 | -0.59 | -1.2 | -1.47 |
| OPM % | -193.71% | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0.96 | 0.26 | 2.04 | 0.01 | 0.02 | 0.24 | 0.09 | 0 | 0.23 | 0.04 | 0.04 | 0.22 | 0.08 |
| Interest | 3.04 | 0.62 | 0 | 0 | 0.04 | 0.11 | 0.25 | 0.01 | 0.03 | 0 | 0 | 0 | 0.01 |
| Depreciation | 1.41 | 1.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -26.6 | -11.68 | 1.53 | -13.61 | -1.01 | -0.76 | -1 | -0.83 | -0.64 | -0.87 | -0.55 | -0.98 | -1.4 |
| Tax % | 3.8% | -12.76% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | -27.61 | -10.19 | 1.53 | -13.61 | -1.01 | -0.76 | -1 | -0.83 | -0.64 | -0.87 | -0.55 | -0.98 | -1.4 |
| EPS in Rs | -14.36 | -5.3 | 0.8 | -7.08 | -0.53 | -0.4 | -0.52 | -0.43 | -0.33 | -0.45 | -0.29 | -0.51 | -0.73 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 |
| Reserves | -13.96 | -34.84 | -33.31 | -46.72 | -46.73 | -45.42 | -44.11 | -44.48 | -44.96 | -45.8 | -46.35 | -47.33 |
| Borrowings | 27.57 | 34.89 | 35.05 | 35.07 | 35.09 | 34.94 | 33.69 | 34.12 | 34.1 | 34.45 | 34.95 | 35.02 |
| Other Liabilities | 11.36 | 14.4 | 12.33 | 12.52 | 12.44 | 11.44 | 11.57 | 11.4 | 11.72 | 12.01 | 12.15 | 12.99 |
| Total Liabilities | 44.18 | 33.66 | 33.28 | 20.08 | 20.01 | 20.17 | 20.36 | 20.25 | 20.07 | 19.87 | 19.96 | 19.89 |
| Fixed Assets | 23.1 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.78 | 18.7 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.1 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20.98 | 14.83 | 14.45 | 1.25 | 1.18 | 1.34 | 1.53 | 1.47 | 1.29 | 1.09 | 1.18 | 1.19 |
| Total Assets | 44.18 | 33.66 | 33.28 | 20.08 | 20.01 | 20.17 | 20.36 | 20.25 | 20.07 | 19.87 | 19.96 | 19.89 |
Cash Flow
| Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -3.7 | — | — | -0.23 | -1.08 | -1.95 | -2.26 | -1 | -0.33 | -0.56 | -0.45 | -0.18 |
| Investing | -0.98 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | 0.09 |
| Financing | 3.48 | — | — | 0.22 | 1.07 | 2.07 | 2.37 | 1.02 | 0.14 | 0.38 | 0.5 | 0.07 |
| Net Cash Flow | -1.2 | — | — | -0.01 | -0.01 | 0.12 | 0.11 | 0.01 | -0.19 | -0.18 | 0.04 | -0.03 |
| Free Cash Flow | -4.95 | — | — | -0.23 | -1.08 | -1.95 | -2.26 | -1 | -0.33 | -0.56 | -0.46 | -0.09 |
| CFO/OP | 12 | — | — | 2 | 109 | 219 | 269 | 122 | 39 | 62 | 76 | 15 |
Ratios
| Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96.68 | — | — | — | — | — | — | — | — | — | — | — |
| Inventory Days | 74.96 | 0 | — | — | — | — | — | — | — | — | — | — |
| Days Payable | 42.65 | — | — | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 129 | — | — | — | — | — | — | — | — | — | — | — |
| Working Capital Days | 377 | — | — | — | — | — | — | — | — | — | — | — |
| ROCE % | -51.93% | — | 7.61% | -95.48% | -12.82% | -7.98% | -8.56% | -9.3% | -7.09% | -10.73% | -7.02% | -13.32% |
Documents
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Jan 2020 - Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December 2019. 9 Jan 2020 - Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December 2019.
4
Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
23 Jan 2020 - Hon''ble NCLT, Mumbai Bench has approved the Resolution Plan submitted by IPCA Laboratories Limited for Noble Explochem Limited vide order dated 22nd January 2020. 23 Jan 2020 - Hon''ble NCLT, Mumbai Bench has approved the Resolution Plan submitted by IPCA Laboratories Limited for Noble Explochem Limited vide order dated 22nd January 2020.
Frequently Asked Questions about Noble Explochem Ltd
What does Noble Explochem Ltd do?
Noble Explochem is principally engaged in the production of explosives. The Company manufactures emulsion-based explosives and petrochemicals.
Where is Noble Explochem Ltd (506991) listed?
Noble Explochem Ltd is listed on the Indian stock exchanges. It is listed on BSE: 506991. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Noble Explochem Ltd belong to?
Noble Explochem Ltd operates in the Commodities sector within the Chemicals & Petrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Noble Explochem Ltd on Tapetide?
On Tapetide, you can view Noble Explochem Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Noble Explochem is principally engaged in the production of explosives. The Company manufactures emulsion-based explosives and petrochemicals.